ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0750

Clinical Characteristics, Kidney Replacement Therapy Exposure, and Intensive Care Unit Outcomes in Cardiac Surgery-Associated AKI Requiring Kidney Replacement Therapy

Session Information

Category: Acute Kidney Injury

  • 102 AKI: Clinical, Outcomes, and Trials

Authors

  • Avdiu, Alban, Robert-Bosch-Krankenhaus GmbH, Stuttgart, BW, Germany
  • Christ, Micha, Robert-Bosch-Krankenhaus GmbH, Stuttgart, BW, Germany
  • Kraft, Leonie, Robert-Bosch-Krankenhaus GmbH, Stuttgart, BW, Germany
  • Oberacker, Tina, Robert-Bosch-Krankenhaus GmbH, Stuttgart, BW, Germany
  • Schricker, Severin, Robert-Bosch-Krankenhaus GmbH, Stuttgart, BW, Germany
  • Fuchs, Moritz, Robert-Bosch-Krankenhaus GmbH, Stuttgart, BW, Germany
  • Nico, Schmid, Robert-Bosch-Krankenhaus GmbH, Stuttgart, BW, Germany
  • Goebel, Nora, Robert-Bosch-Krankenhaus GmbH, Stuttgart, BW, Germany
  • Heyne, Nils, Universitatsklinikum Tubingen, Tübingen, BW, Germany
  • Latus, Joerg, Robert-Bosch-Krankenhaus GmbH, Stuttgart, BW, Germany
  • Schanz, Moritz, Robert-Bosch-Krankenhaus GmbH, Stuttgart, BW, Germany
Background

Cardiac surgery-associated acute kidney injury (CSA-AKI) requiring kidney replacement therapy (KRT) represents the most severe phenotype of perioperative kidney injury and is associated with substantial morbidity and mortality. Detailed KRT exposure remains limited in contemporary cohorts.

Methods

We conducted a retrospective single-center cohort study of 547 adult patients who developed AKI requiring KRT during intensive care unit (ICU) stay after cardiac surgery from July 2017 to February 2024. Perioperative characteristics, timing and duration of KRT and ICU mortality were analyzed. Multivariable logistic regression models identified factors associated with ICU mortality and prolonged KRT (≥7 days and ≥14 days).

Results

Median age was 71 years (IQR 62–77); 32.0% were female. Pre-existing CKD was present in 30.9%, diabetes in 31.6%, and heart failure in 74.6%. Median time from ICU admission to first AKI stage was 10.3 hours (IQR 7.8–14.4), and to KRT initiation 58.3 hours (IQR 29.5–107.4). ICU mortality was 35.6%. Median KRT duration was 4.0 days (IQR 1.0–12.0); prolonged KRT for ≥7 days and ≥14 days occurred in 38.9% and 20.8% of patients, respectively (Table 1). In multivariable analysis, pre-existing heart failure was independently associated with ICU mortality (OR 1.83, p=0.034). Initial AKI stage 2 (OR 2.99, p=0.038) and longer bypass time (OR 1.009 per minute, p=0.019) were associated with prolonged KRT. Initial AKI stage 3 showed inverse association, possibly reflecting competing mortality risk.

Conclusion

CSA-AKI requiring KRT is characterized by rapid AKI onset and substantial KRT burden. Pre-existing heart failure and prolonged bypass time are key determinants of adverse short-term outcomes. These findings describe the early KRT burden in severe CSA-AKI and support subsequent long-term analyses focusing on dialysis dependence and renal recovery.

Acknowledgment

Generative AI support was used for language editing: ChatGPT.